A new patent was granted from Korean Intelletual Property Office (KIPO)

Boston, April 19, 2022 – Ab Biosciences, Inc., a biotechnology company developing biologics for chronic inflammatory and autoimmune diseases, today announced that it has received a new patent from the Korean Intellectual Property Office (KIPO, KR10-2477536).